Le cannabis — données neurobiologiques récentes éclairant les perturbations de la conduite des véhicules

Costes, 2002, Données épidémiologiques récentes sur les drogues illicites en France: prévalence et conséquences sanitaires des consommations, disponibilité et qualité des produits, Bull Acad Natle Med, 186, 281

Bello, 2005, Les usagers fréquents de cannabis, éléments descriptifs, France 2004, BEH, 20, 89

Gaoni, 1971, The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashih, J Am Chem Soc, 93, 217, 10.1021/ja00730a036

Smith-Kielland, 1999, Urinary excretion of 11-Nor-9 carboxy-delta-9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users, J Anal Toxicol, 23, 323, 10.1093/jat/23.5.323

Tsou, 1995, Physical withdrawal in rats tolerant to delta-9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist, European J Pharmacol, 280, R13, 10.1016/0014-2999(95)00360-W

Aceto, 1996, Dependance studies on delta-9-tetrahydrocannabinol/studies on precipitated and abrupt withdrawal, J Pharmacol Exp Ther, 278, 1290

Cook, 1998, CB1 receptor antagonist precipitates withdrawal in mice chronically exposed to delta-9-tetrahydrocannabinol, J Pharmacol Exp Ther, 885, 1150

Lichtman, 1998, Effects of SR 141716A after acute or chronic cannabinoid administration in dogs, European J Pharmacol, 18, 139, 10.1016/S0014-2999(98)00558-5

Hutcheson, 1998, Behavioral and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol, Brit J Pharmacol, 125, 1567, 10.1038/sj.bjp.0702228

Beardsley, 2000, Effects of the CB1 antagonist SR 141716A, after delta-9-tetrahydrocannabinol withdrawal, European J Pharmacol, 387, 47, 10.1016/S0014-2999(99)00792-X

Gifford, 1999, Large receptor reserve for cannabinoid actions in the central nervous system, J Pharmacol Exp Ther, 288, 478

Matsuda, 1990, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561, 10.1038/346561a0

Ledent, 1999, Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1. knock out mice, Science, 283, 401, 10.1126/science.283.5400.401

Herkenham, 1991, Characterization and localization of cannabinoid receptors in rat brain. A quantitative in vitro autoradiographic study, J Neurosci, 11, 563, 10.1523/JNEUROSCI.11-02-00563.1991

Devane, 1992, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, 258, 1946, 10.1126/science.1470919

Di Marzo, 1994, Formation and inactivation of endogenous cannabinoid anandamide in central neurons, Nature, 372, 686, 10.1038/372686a0

Piomelli, 2001, The ligand that came from within, Trends Pharmacol Sci, 22, 17, 10.1016/S0165-6147(00)01602-3

Kreitzer, 2002, Retrograde signaling by endocannabinoids, Curr Opin Neurobiol, 12, 324, 10.1016/S0959-4388(02)00328-8

Robbe, 2001, Localization and mechanism of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens, J Neurosci, 21, 109, 10.1523/JNEUROSCI.21-01-00109.2001

Doherty, 2003, Functional interactions between cannabinoids and metabotropic glutamate receptors in the central nervous system, Curr Opin Pharmacol, 3, 46, 10.1016/S1471-4892(02)00014-0

Cravatt, 1996, Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides, Nature, 384, 83, 10.1038/384083a0

Leirier, 1991, Marijuana carry-over effects on aircraft pilot performance, Aviations and Space Environmental Medicine, 62, 221

Regier, 1990, Comorbidity of mental disorders with alcohol and other drugs of abuse. Results from the Epidemiologic Catchment Area Study, JAMA, 264, 2511, 10.1001/jama.1990.03450190043026

Choquet, 2004, À 17 ans, un adolescent sur six consomme régulièrement du cannabis, 17

Andreasson, 1987, Cannabis and schizophrenia. A longitudinal study of Swedish conscripts, Lancet, 1483, 10.1016/S0140-6736(87)92620-1

Zammit, 2002, Self reported cannabis use as risk factor for schizophrenia in Swedish conscripts of 1979. Historical cohort study, Brit Med J, 325, 1199, 10.1136/bmj.325.7374.1199

Mura, 2005, THC can be detected in brain while absent in blood, J Anal Toxicol, 29, 1, 10.1093/jat/29.8.842

Gallatte, 1999, Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist, European J Pharmacol, 370, 233, 10.1016/S0014-2999(99)00170-3

Colombo, 2002, Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol – preferring SP rats, Pychopharmacol, 159, 181, 10.1007/s002130100887

Arnone, 1997, Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors, Psychopharmacol, 132, 104, 10.1007/s002130050326

Serra, 2001, The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behaviour in alcohol – preferring rats, European J Pharmacol, 430, 369, 10.1016/S0014-2999(01)01379-6

Freedland, 2001, Effects of SR 141716 A on ethanol and sucrose self administration, Alcohol Clin Exp Res, 25, 277, 10.1111/j.1530-0277.2001.tb02209.x

Hungund, 2003, Cannabinoid CB1 receptor knock out mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens, J Neurochem, 84, 882, 10.1046/j.1471-4159.2003.01576.x

Bassavarajappa, 2002, Neuromodulatory role of the endocannabinoid signalling system in alcoholism:an overview, Prostaglandins Leukot Essent Fatty Acids, 66, 287, 10.1054/plef.2001.0352

Yao, 2003, Addicting drugs utilize a synergistic molecular mechanism in common, requiring adenosine and Gi-P dimers, Proc Nat Acad Sci, 100, 14379, 10.1073/pnas.2336093100

Chaperon, 1998, Involvement of central cannabinoid CB1 receptor in the establishment of place conditioning in rats, Psychopharmacol, 135, 324, 10.1007/s002130050518

Tanda, 1997, Cannabinoid and heroin activation of mesolimbic dopaminergic transmission by a common μ1 opioid receptor mechanism, Science, 276, 2048, 10.1126/science.276.5321.2048

Mascia, 1999, Lack of morphine – induced dopamine release in the nucleus accumbens of cannabinoid CB1 receptor knock out mice, European J Pharmacol, 383, R1, 10.1016/S0014-2999(99)00656-1

Navarro, 1998, Cannabinoid receptor antagonist - induced opiate withdrawal in morphine dependent rats, Neuro Report, 9, 3397